SCHEMBL4636112

SCHEMBL4636112

CCOC(=O)Cc1c(C)c(Cc2ccc3cc(F)ccc3n2)c2cc(Cl)ccn12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGIR P43119 1/20 0.38
PTGDR Q13258 1/20 0.38
PTGDR2 Q9Y5Y4 1/20 0.38
TSHR P16473 1/20 0.37
MAOB P27338 3/20 0.35
ALOX5AP P20292 1/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
POLB P06746 1/20 0.35
HPGD P15428 1/20 0.35
HTT P42858 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
PDE10A Q9Y233 2/20 0.34
ALDH1A1 P00352 2/20 0.34
HK1 P19367 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HKDC1 Q2TB90 1/20 0.34
SLC2A2 P11168 1/20 0.33
MAPT P10636 2/20 0.33
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4636883 0.89 PTGDR2 (0.44) PTGIRPTGDRPTGDR2ALOX5APPDE10A
SCHEMBL3327331 0.87 PTGIR (0.36) PTGIRPTGDRPTGDR2TSHRMAOB
SCHEMBL3327259 0.76 PTGDR2 (0.42) PTGIRPTGDRPTGDR2ALOX5APMEN1
SCHEMBL3577485 0.73 TSHR (0.38) PTGIRPTGDRPTGDR2TSHRMAOB
SCHEMBL4636111 0.67 MAPT (0.38) TSHRMEN1KMT2APOLBHPGD
SCHEMBL14176165 0.66 PTGDR2 (0.44) PTGIRPTGDRPTGDR2TSHRALOX5AP
SCHEMBL4635635 0.65 PTGDR2 (0.44) PTGDR2TSHRKMT2AALDH1A1
SCHEMBL3567666 0.64 PTGDR2 (0.42) PTGIRPTGDRPTGDR2PDE10AHDAC1
SCHEMBL3260069 0.64 PTGDR2 (0.79) PTGIRPTGDRPTGDR2TSHRMEN1
SCHEMBL4635700 0.63 ALDH1A1 (0.40) TSHRMEN1KMT2APOLBHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080306109-A1 Indolizine Derivatives as Ligands of the Crth2 Receptor ARGENTA DISCOVERY LIMITED (GB) 2008-12-11 US disclosed
EP-1931663-A1 IMDOLIZINE DERIVATIVES AS LIGANDS OF THE CRTH2 RECEPTOR Argenta Discovery Limited (GB) 2008-06-18 EP disclosed
WO-2007031747-A1 IMDOLIZINE DERIVATIVES AS LIGANDS OF THE CRTH2 RECEPTOR ARGENTA DISCOVERY LIMITED (GB) 2007-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080306109-A1 Indolizine Derivatives as Ligands of the Crth2 Receptor HRH4, HRH2, HRH3 PTGIR 462/4885PTGDR 249/4885PTGDR2 293/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.